Rupert Vessey, Flagship Pioneering chief scientist

Af­ter eject­ing out of Bris­tol My­ers R&D, Ru­pert Vessey lands at the top sci­ence post at a buzzy Flag­ship

Five months ago, Ru­pert Vessey stepped out of his in­flu­en­tial R&D post at Bris­tol My­ers Squibb in a move clear­ly point­ing to a new, though unan­nounced, chap­ter in biotech. And he un­veiled his next ca­reer step to­day with the news that he’s join­ing a buzzy Flag­ship Pi­o­neer­ing as their chief sci­en­tist.

It’s a brand new po­si­tion.

The move takes him out of a Big Phar­ma that’s been work­ing, some­times strug­gling, to man­age a ma­jor pipeline — in­clud­ing a host of drugs Vessey arranged to in-li­cense for big bucks — and puts him square­ly at one of the largest ven­ture groups in biotech, where he’ll be wide­ly fa­mil­iar to the peo­ple mus­ter­ing new com­pa­nies around some emerg­ing tech­nolo­gies.

Endpoints Premium

This article is for premium subscribers only

Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.